STAT News

STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies

Rare disease advocates applauded the FDA's move to speed access to treatments.

By STAT News

1 min read
STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights